GlassScriptPhysician profile
Faraz A Syed
NPI 1033264817
$4,600.24
in general payments reported to CMS, 2019-2025
16 companies · $161 in 2025
The $161 reported for 2025 was more than what 76% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176 · 2020: $23.79 · 2021: $287 · 2022: $13.78 · 2023: $2,535 · 2024: $1,403 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,750 · Food and Beverage: $349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,750.00 |
| Food and Beverage | $349.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $3,750.00 | 2023-2024 | Bd Intelliport |
| Chiesi USA, INC. | $172.08 | 2019-2024 | Cleviprex |
| Edwards Lifesciences Corporation | $162.22 | 2021 | |
| Abbvie INC. | $124.98 | 2025 | |
| Merck Sharp & Dohme LLC | $94.19 | 2019-2025 | Bridion |
| Abiomed | $66.45 | 2024 | Impella |
| Cumberland Pharmaceuticals, INC. | $53.00 | 2019-2025 | Caldolor |
| Mindray Ds USA, INC. | $37.30 | 2024 | Te X, Te7 Max |
| Astrazeneca Pharmaceuticals LP | $30.89 | 2021-2024 | Andexxa |
| Shionogi INC | $26.29 | 2019-2024 | Fetroja |
| Janssen Biotech, INC. | $15.00 | 2019 | |
| Mallinckrodt Enterprises LLC | $14.59 | 2019 | |
| Amag Pharmaceuticals, INC. | $14.13 | 2019 | |
| Heron Therapeutics, INC. | $13.78 | 2022 | |
| Allergan, INC. | $13.41 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.93 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Faraz Syed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.